Logo image of ACT

ENACT HOLDINGS INC (ACT) Stock Fundamental Analysis

NASDAQ:ACT - US29249E1091 - Common Stock

38.57 USD
+0.17 (+0.44%)
Last: 9/5/2025, 8:00:01 PM
38.57 USD
0 (0%)
After Hours: 9/5/2025, 8:00:01 PM
Fundamental Rating

5

Taking everything into account, ACT scores 5 out of 10 in our fundamental rating. ACT was compared to 102 industry peers in the Financial Services industry. Both the profitability and the financial health of ACT get a neutral evaluation. Nothing too spectacular is happening here. ACT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ACT had positive earnings in the past year.
ACT had a positive operating cash flow in the past year.
Each year in the past 5 years ACT has been profitable.
Each year in the past 5 years ACT had a positive operating cash flow.
ACT Yearly Net Income VS EBIT VS OCF VS FCFACT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 9.99%, ACT belongs to the top of the industry, outperforming 90.20% of the companies in the same industry.
ACT's Return On Equity of 12.96% is fine compared to the rest of the industry. ACT outperforms 67.65% of its industry peers.
Industry RankSector Rank
ROA 9.99%
ROE 12.96%
ROIC N/A
ROA(3y)11.21%
ROA(5y)9.9%
ROE(3y)15.1%
ROE(5y)13.63%
ROIC(3y)N/A
ROIC(5y)N/A
ACT Yearly ROA, ROE, ROICACT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

ACT's Profit Margin of 55.35% is amongst the best of the industry. ACT outperforms 93.14% of its industry peers.
ACT's Profit Margin has declined in the last couple of years.
The Operating Margin of ACT (74.60%) is better than 95.10% of its industry peers.
ACT's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 74.6%
PM (TTM) 55.35%
GM N/A
OM growth 3Y5.43%
OM growth 5Y1.29%
PM growth 3Y5.4%
PM growth 5Y-3.72%
GM growth 3YN/A
GM growth 5YN/A
ACT Yearly Profit, Operating, Gross MarginsACT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, ACT has less shares outstanding
ACT has less shares outstanding than it did 5 years ago.
ACT has a better debt/assets ratio than last year.
ACT Yearly Shares OutstandingACT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACT Yearly Total Debt VS Total AssetsACT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

The Debt to FCF ratio of ACT is 1.06, which is an excellent value as it means it would take ACT, only 1.06 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ACT (1.06) is better than 85.29% of its industry peers.
ACT has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ACT (0.14) is better than 76.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.06
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
ACT Yearly LT Debt VS Equity VS FCFACT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ACT Yearly Current Assets VS Current LiabilitesACT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2021 2022 2023 2024 5M 10M 15M 20M

4

3. Growth

3.1 Past

ACT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.41%.
Measured over the past 5 years, ACT shows a small growth in Earnings Per Share. The EPS has been growing by 0.98% on average per year.
The Revenue has been growing slightly by 3.16% in the past year.
Measured over the past years, ACT shows a small growth in Revenue. The Revenue has been growing by 4.19% on average per year.
EPS 1Y (TTM)4.41%
EPS 3Y9.13%
EPS 5Y0.98%
EPS Q2Q%-9.45%
Revenue 1Y (TTM)3.16%
Revenue growth 3Y2.44%
Revenue growth 5Y4.19%
Sales Q2Q%2.03%

3.2 Future

Based on estimates for the next years, ACT will show a small growth in Earnings Per Share. The EPS will grow by 2.68% on average per year.
ACT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.96% yearly.
EPS Next Y-3.43%
EPS Next 2Y0.2%
EPS Next 3Y2.68%
EPS Next 5YN/A
Revenue Next Year2.04%
Revenue Next 2Y2.78%
Revenue Next 3Y2.96%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACT Yearly Revenue VS EstimatesACT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ACT Yearly EPS VS EstimatesACT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.57, the valuation of ACT can be described as reasonable.
Based on the Price/Earnings ratio, ACT is valued cheaply inside the industry as 81.37% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.06. ACT is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 8.42, which indicates a very decent valuation of ACT.
Based on the Price/Forward Earnings ratio, ACT is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.69. ACT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.57
Fwd PE 8.42
ACT Price Earnings VS Forward Price EarningsACT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ACT is valued cheaply inside the industry as 81.37% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.12
EV/EBITDA N/A
ACT Per share dataACT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)8.77
EPS Next 2Y0.2%
EPS Next 3Y2.68%

4

5. Dividend

5.1 Amount

ACT has a Yearly Dividend Yield of 2.19%.
ACT's Dividend Yield is a higher than the industry average which is at 4.58.
ACT's Dividend Yield is comparable with the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 2.19%

5.2 History

ACT has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ACT Yearly Dividends per shareACT Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

17.25% of the earnings are spent on dividend by ACT. This is a low number and sustainable payout ratio.
DP17.25%
EPS Next 2Y0.2%
EPS Next 3Y2.68%
ACT Yearly Income VS Free CF VS DividendACT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
ACT Dividend Payout.ACT Dividend Payout, showing the Payout Ratio.ACT Dividend Payout.PayoutRetained Earnings

ENACT HOLDINGS INC

NASDAQ:ACT (9/5/2025, 8:00:01 PM)

After market: 38.57 0 (0%)

38.57

+0.17 (+0.44%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners20.16%
Inst Owner Change6.06%
Ins Owners0.43%
Ins Owner Change-2.74%
Market Cap5.69B
Analysts76
Price Target40.8 (5.78%)
Short Float %11.62%
Short Ratio8.92
Dividend
Industry RankSector Rank
Dividend Yield 2.19%
Yearly Dividend0.72
Dividend Growth(5Y)N/A
DP17.25%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-18 2025-08-18 (0.21)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.18%
Min EPS beat(2)1.16%
Max EPS beat(2)3.2%
EPS beat(4)4
Avg EPS beat(4)5.92%
Min EPS beat(4)1.16%
Max EPS beat(4)15.04%
EPS beat(8)8
Avg EPS beat(8)9.69%
EPS beat(12)12
Avg EPS beat(12)14.26%
EPS beat(16)16
Avg EPS beat(16)15.63%
Revenue beat(2)1
Avg Revenue beat(2)-0.68%
Min Revenue beat(2)-1.86%
Max Revenue beat(2)0.5%
Revenue beat(4)2
Avg Revenue beat(4)-1.14%
Min Revenue beat(4)-3.4%
Max Revenue beat(4)0.5%
Revenue beat(8)3
Avg Revenue beat(8)-0.9%
Revenue beat(12)4
Avg Revenue beat(12)-0.85%
Revenue beat(16)5
Avg Revenue beat(16)-1%
PT rev (1m)0%
PT rev (3m)1.27%
EPS NQ rev (1m)0.37%
EPS NQ rev (3m)-1.1%
EPS NY rev (1m)0.27%
EPS NY rev (3m)0.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.22%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 8.57
Fwd PE 8.42
P/S 4.65
P/FCF 8.12
P/OCF 8.12
P/B 1.09
P/tB 1.09
EV/EBITDA N/A
EPS(TTM)4.5
EY11.67%
EPS(NY)4.58
Fwd EY11.87%
FCF(TTM)4.75
FCFY12.31%
OCF(TTM)4.75
OCFY12.31%
SpS8.29
BVpS35.41
TBVpS35.41
PEG (NY)N/A
PEG (5Y)8.77
Profitability
Industry RankSector Rank
ROA 9.99%
ROE 12.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 74.6%
PM (TTM) 55.35%
GM N/A
FCFM 57.28%
ROA(3y)11.21%
ROA(5y)9.9%
ROE(3y)15.1%
ROE(5y)13.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.25%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y5.43%
OM growth 5Y1.29%
PM growth 3Y5.4%
PM growth 5Y-3.72%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.06
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 103.47%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)91.43%
Profit Quality(5y)113.82%
High Growth Momentum
Growth
EPS 1Y (TTM)4.41%
EPS 3Y9.13%
EPS 5Y0.98%
EPS Q2Q%-9.45%
EPS Next Y-3.43%
EPS Next 2Y0.2%
EPS Next 3Y2.68%
EPS Next 5YN/A
Revenue 1Y (TTM)3.16%
Revenue growth 3Y2.44%
Revenue growth 5Y4.19%
Sales Q2Q%2.03%
Revenue Next Year2.04%
Revenue Next 2Y2.78%
Revenue Next 3Y2.96%
Revenue Next 5YN/A
EBIT growth 1Y-0.5%
EBIT growth 3Y8.01%
EBIT growth 5Y5.53%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.3%
FCF growth 3Y6.25%
FCF growth 5Y6.54%
OCF growth 1Y28.3%
OCF growth 3Y6.25%
OCF growth 5Y6.54%